Marcy l’Etoile – French in vitro diagnostics group Biomérieux S.A. informed the markets that it has acquired Argene, a French company specialising in molecular diagnostics for immunocompromised patients. Biomérieux said it was acquiring 100% of A.B. Services, the holding company that owns Argene, for EUR37.5m, plus up to EUR5m in milestones. Argene has 70 employees worldwide, and generated sales of around EUR10m in 2010. The acquired firm specialises in molecular diagnostics for infectious diseases such as cytomegalovirus, Epstein-Barr virus and the herpes simplex viruses 1 and 2.